Literature DB >> 7726495

Distribution of cphA or related carbapenemase-encoding genes and production of carbapenemase activity in members of the genus Aeromonas.

G M Rossolini1, A Zanchi, A Chiesurin, G Amicosante, G Satta, P Guglielmetti.   

Abstract

The prevalence of the cphA gene or related carbapenemase-encoding genes was investigated in 114 Aeromonas strains belonging to the six species of major clinical interest. A species-related distribution of cphA-related sequences was observed. Similar sequences were found in A. hydrophila, A. veronii bv. sobria, A. veronii bv. veronii, and A. jandaei, but not in A. caviae, A. trota, or A. schubertii. However, a single A. caviae strain (of 62 tested) was found carrying cphA-related sequences, suggesting the possibility of the horizontal transfer of this gene to species which normally do not carry it. Production of carbapenemase activity was detectable in 83% of the hybridization-positive strains but in none of the hybridization-negative ones. When it was present, carbapenemase activity was always inhibitable by EDTA. Either carbapenemase-producing or not, Aeromonas strains appeared to be susceptible to imipenem when in vitro susceptibility testing was performed with inocula of conventional size (10(5) CFU), for which MICs were always < or = 1 microgram/ml. With a larger inoculum (10(8) CFU), the MICs for carbapenemase-negative strains always remained < or = 1 microgram/ml, while those for carbapenemase-producing strains were always > or = 4 micrograms/ml, being usually higher than the breakpoint for susceptibility. The present results indicate that the production of metallocarbapenemase activity, apparently encoded by cphA homologs, is widespread among some of the Aeromonas species of clinical interest (A. hydrophila, A. veronii bv. sobria, A. veronii bv. veronii, and A. jandaei) and that imipenem MICs for carbapenemase-producing strains are subjected to a relevant inoculum size effect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726495      PMCID: PMC162540          DOI: 10.1128/AAC.39.2.346

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.

Authors:  H C Neu; A Novelli; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

2.  Sequencing the gene for an imipenem-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus beta-lactamase II.

Authors:  J S Thompson; M H Malamy
Journal:  J Bacteriol       Date:  1990-05       Impact factor: 3.490

3.  Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia.

Authors:  Y Saino; F Kobayashi; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

4.  Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases.

Authors:  C C Sanders; W E Sanders; K S Thomson; J P Iaconis
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

5.  In-vitro activity of meropenem against clinical isolates obtained in Canada.

Authors:  A M Clarke; S J Zemcov
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

6.  Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.

Authors:  J S Bakken; C C Sanders; R B Clark; M Hori
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

7.  Kinetic analysis of extension of substrate specificity with Xanthomonas maltophilia, Aeromonas hydrophila, and Bacillus cereus metallo-beta-lactamases.

Authors:  A Felici; G Amicosante
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

8.  Purification and characterization of inducible beta-lactamases in Aeromonas spp.

Authors:  J P Iaconis; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

9.  Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila.

Authors:  K Shannon; A King; I Phillips
Journal:  J Antimicrob Chemother       Date:  1986-01       Impact factor: 5.790

10.  Cloning and sequencing of the metallothioprotein beta-lactamase II gene of Bacillus cereus 569/H in Escherichia coli.

Authors:  M Hussain; A Carlino; M J Madonna; J O Lampen
Journal:  J Bacteriol       Date:  1985-10       Impact factor: 3.490

View more
  13 in total

1.  Aeromonas Isolates from Fish and Patients in Tainan City, Taiwan: Genotypic and Phenotypic Characteristics.

Authors:  Chi-Jung Wu; Wen-Chien Ko; Nan-Yao Lee; Shu-Li Su; Chia-Wen Li; Ming-Chi Li; Yi-Wei Chen; Yu-Cheng Su; Cing-Ying Shu; Yu-Tzu Lin; Po-Lin Chen
Journal:  Appl Environ Microbiol       Date:  2019-10-16       Impact factor: 4.792

2.  Identification of Aeromonas clinical isolates by restriction fragment length polymorphism of PCR-amplified 16S rRNA genes.

Authors:  N Borrell; S G Acinas; M J Figueras; A J Martínez-Murcia
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

3.  Which antibiotics and breakpoints should be used for Aeromonas susceptibility testing? Considerations from a comparison of agar dilution and disk diffusion methods using Enterobacteriaceae breakpoints.

Authors:  B Lamy; F Laurent; A Kodjo; F Roger; E Jumas-Bilak; H Marchandin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-27       Impact factor: 3.267

Review 4.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

5.  Bacteremia due to extended-spectrum-β-lactamase-producing Aeromonas spp. at a medical center in Southern Taiwan.

Authors:  Chi-Jung Wu; Yin-Ching Chuang; Mei-Feng Lee; Chin-Chi Lee; Hsin-Chun Lee; Nan-Yao Lee; Chia-Ming Chang; Po-Lin Chen; Yu-Tzu Lin; Jing-Jou Yan; Wen-Chien Ko
Journal:  Antimicrob Agents Chemother       Date:  2011-10-03       Impact factor: 5.191

6.  Detection of CTX-M-type beta-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru.

Authors:  Lucia Pallecchi; Monica Malossi; Antonia Mantella; Eduardo Gotuzzo; Christian Trigoso; Alessandro Bartoloni; Franco Paradisi; Göran Kronvall; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

Review 7.  The genus Aeromonas: taxonomy, pathogenicity, and infection.

Authors:  J Michael Janda; Sharon L Abbott
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

8.  Clinical implications of species identification in monomicrobial Aeromonas bacteremia.

Authors:  Chi-Jung Wu; Po-Lin Chen; Po-Ren Hsueh; Ming-Chung Chang; Pei-Jane Tsai; Hsin-I Shih; Hsuan-Chen Wang; Pei-Hsin Chou; Wen-Chien Ko
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

Review 9.  Aeromonas dhakensis, an Increasingly Recognized Human Pathogen.

Authors:  Po-Lin Chen; Brigitte Lamy; Wen-Chien Ko
Journal:  Front Microbiol       Date:  2016-05-27       Impact factor: 5.640

10.  Nucleotide and amino acid sequences of the metallo-beta-lactamase, ImiS, from Aeromonas veronii bv. sobria.

Authors:  T R Walsh; W A Neville; M H Haran; D Tolson; D J Payne; J H Bateson; A P MacGowan; P M Bennett
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.